$6M grant for new Open Science patient registry
Goal is to accelerate research and let patients know how their data is helping find treatmentsA $6M grant from Brain Canada will fund the creation of a new Open Science patient registry, to share data with researchers around the world and let patients see how their data is used to develop new treatments for neurological disorders.
Alpha Tau and the JGH Announce Alpha DaRT Treatment of First Patient in its Advanced Pancreatic Cancer Clinical Trial
Alpha Tau Medical Ltd. the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that its first patient with advanced inoperable pancreatic cancer has been treated in a feasibility and safety study of Alpha DaRT at the Jewish General Hospital (JGH) in Montreal, Canada, which is an affiliated teaching hospital of McGill University, Faculty of Medicine.
Genes reveal kidney cancer’s risk of recurrence
Studying the mutations in kidney cancer after surgery could help to better predict the risk of the disease coming back, according to the latest results of a decade-long international study.
The research, undertaken by a team of 44 researchers at 23 institutions across Europe and Canada, including McGill University, is the largest to link the genetic changes that occur in kidney cancer to patient outcomes.
McGill researchers’ studies offer promise for lung and brain cancer treatment
Two seminal studies from McGill University, investigating immune landscapes of lung and brain tumours, were published today in Nature. This work was led by Logan Walsh, Daniela Quail and Peter Siegel, researchers at the Rosalind and Morris Goodman Cancer Institute and Philippe Joubert from Université Laval.
Study finds obesity-related neurodegeneration mimics Alzheimer’s disease
Thinning in the right temporo-parietal cortex and left prefrontal cortex were similar in both groupsA new study led by scientists at The Neuro (Montreal Neurological Institute-Hospital) of McGill University finds a correlation between neurodegeneration in obese people and Alzheimer’s disease (AD) patients.
Neuro director to co-chair new national clinical trial initiative
Consortium brings together hundreds of researchers from 28 networks, 11 trial units across the countryToday the Canadian Institutes of Health Research (CIHR) announced funding for a new clinical trial consortium co-chaired by Dr.
Frequent genetic cause of late-onset ataxia uncovered by a Quebec-led international collaboration
Discovery will improve diagnosis and open treatment possibilities for thousands of people with this debilitating neurodegenerative condition worldwideA new study published on Dec. 14, 2022 in the New England Journal of Medicine reports the identification of a previously unknown genetic cause of a late-onset cerebellar ataxia, a discovery that will improve diagnosis and open new treatment avenues for this progressive condition.
Message from VP-Dean Eidelman - The Faculty's Return to Campus
Dear Faculty of Medicine and Health Sciences Colleagues,
Marathon of Hope Cancer Centres Network accelerates precision medicine plan with signing of Contribution Agreement with Health Canada
Vancouver, BC -- The Government of Canada and the Terry Fox Research Institute (TFRI) have jointly signed a Contribution Agreement which opens the door for the Marathon of Hope Cancer Centres Network to begin operating.
McGill researcher-led International Task Force unveils first-of-its kind standards for treatment of obsessive-compulsive disorder
By David McFadden
Listed by the World Health Organization among the ten leading causes of medical disability worldwide, the severity of obsessive-compulsive disorder (OCD) is at a level on par with cancer. This prevalent disorder is characterized by highly distressing intrusive thoughts and repeated compulsive behaviours such as washing or checking.
Two cellular pathways involved in TNBC tumour development and a promising targeted combination therapy
A team of researchers at the RI-MUHC found two cellular pathways involved in TNBC tumour development and a promising targeted combination therapy
Source: RI-MUHC
Message from VP-Dean Eidelman - Planning for a return to campus
Dear members of our Faculty community,
Our world has changed since the onset of the COVID-19 pandemic, yet we have persevered to continue to offer world-class education and conduct leading research. Indeed, I am immensely proud of our contributions.
Under 30 and sexually active? It’s a good idea to get tested for chlamydia and gonorrhea
Canadian Task Force on Preventive Health Care recommends routine screening
Source: CMAJ
Anyone sexually active under age 30 should be offered testing for chlamydia and gonorrhea, according to a new guideline from the Canadian Task Force on Preventive Health Care published in CMAJ (Canadian Medical Association Journal).
Fertility Frontier: Can Transgender Women Get Uterus Transplants?
By David McFadden
It’s been nearly seven years since the world’s first successful birth after a human womb transplant. Since that medical milestone, the experimental procedure has seen such significant clinical advances that over 60 uterus transplants have been performed in women across the globe, resulting in at least 18 live births.
Infrared imaging could help screen for COVID-19
Technology offers more accurate method to detect illness in minimally symptomatic cases
As the global COVID-19 pandemic has continued to rage across the globe, temperature recordings have been widely used as a screening tool to help detect infected individuals.